| NDC Code | 51285-445-21 |
|---|
| Package Description | 150 mL in 1 BOTTLE (51285-445-21) |
|---|
| Product NDC | 51285-445 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl |
|---|
| Non-Proprietary Name | Erythromycin Ethylsuccinate And Sulfisoxazole Acetyl |
|---|
| Dosage Form | GRANULE, FOR SUSPENSION |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 19980601 |
|---|
| End Marketing Date | 20141130 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA062759 |
|---|
| Manufacturer | Teva Women's Health, Inc. |
|---|
| Substance Name | ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL |
|---|
| Strength | 200; 600 |
|---|
| Strength Unit | mg/5mL; mg/5mL |
|---|
| Pharmacy Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient],Sulfonamide Antimicrobial [EPC],Sulfonamides [Chemical/Ingredient] |
|---|